Literature DB >> 30797588

Transcatheter or surgical repair for degenerative mitral regurgitation in elderly patients: A propensity-weighted analysis.

Nicola Buzzatti1, Mathias Van Hemelrijck2, Paolo Denti3, Stefania Ruggeri3, Davide Schiavi3, Iside Stella Scarfò3, Diana Reser2, Maurizio Taramasso2, Alberto Weber2, Giovanni La Canna3, Michele De Bonis3, Francesco Maisano2, Ottavio Alfieri3.   

Abstract

OBJECTIVE: To compare the outcomes of MitraClip and surgical mitral repair in low-intermediate risk elderly patients affected by degenerative mitral regurgitation (DMR).
METHODS: We retrospectively selected patients aged ≥75 years, with Society of Thoracic Surgeons Predicted Risk Of Mortality (STS-PROM) <8%, submitted to MitraClip (n = 100) or isolated surgical repair (n = 206) for DMR at 2 centers between January 2005 and May 2017. To adjust for baseline imbalances, we used a propensity score model for average treatment effect on survival.
RESULTS: After weighting, MitraClip showed fewer postoperative complications (P < .05) but increased residual mitral regurgitation (MR) ≥2 (27.0% vs 2.8%, P < .001) compared with surgery. One-year survival was greater after MitraClip compared with surgery (97.6% vs 95.3%, hazard ratio [HR], 0.09; confidence interval [CI], 0.02-0.37, P = .001), whereas 5-year survival was lower (34.5% vs 82.2% respectively, HR, 4.12; CI, 2.31-7.34, P < .001). Greater STS-PROM (HR, 1.18; CI, 1.12-1.24, P < .001) and MR ≥3+ recurrence (HR, 2.18; CI, 1.07-4.48, P = .033) were associated with reduced survival. 5-year MR ≥3+ was more frequent after MitraClip compared with surgery: 36.9% versus 3.9%, odds ratio, 11.4; CI, 4.40-29.68, P < .001.
CONCLUSIONS: In elderly patients affected by DMR and STS-PROM <8%, the average effect of MitraClip resulted in lower acute postoperative complications and improved 1-year survival compared with surgery. However, MitraClip was associated with greater MR recurrence and reduced survival beyond 1 year. Long-term survival was impaired by patients' greater risk profile and MR recurrence. Early results are promising, but in the setting of operable patients with life expectancy beyond 1 year, the quality bar for transcatheter mitral repair needs to be raised.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mitraclip; degenerative; mitral regurgitation; mitral repair; prolapse; transcatheter

Year:  2019        PMID: 30797588     DOI: 10.1016/j.jtcvs.2019.01.023

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  3 in total

1.  An updated meta-analysis of MitraClip versus surgery for mitral regurgitation.

Authors:  Nicholas A Oh; Polydoros N Kampaktsis; Michele Gallo; Alvise Guariento; Viktoria Weixler; Steven J Staffa; Dimitrios V Avgerinos; Andrea Colli; Ilias P Doulamis
Journal:  Ann Cardiothorac Surg       Date:  2021-01

2.  What does an explanted PASCAL device look like?

Authors:  Mathias Van Hemelrijck; Juri Sromicki; Martin O Schmiady; Carlos-A Mestres
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-02-21

3.  Heart team approach in treatment of mitral regurgitation: patient selection and outcome.

Authors:  Mischa Külling; Roberto Corti; Georg Noll; Silke Küest; David Hürlimann; Christophe Wyss; Ivano Reho; Felix C Tanner; Jeremy Külling; Nicolai Meinshausen; Oliver Gaemperli; Peter Wenaweser; Sacha P Salzberg; Thierry Aymard; Jürg Grünenfelder; Patric Biaggi
Journal:  Open Heart       Date:  2020-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.